Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1094)
Immunome Inc. (IMNM)
WAGENHEIM PHILIP — Director
Shares
36,800
Price
$20.47
Total Value
$753.30K
Shares Held After
369,347
% of Holdings
9.1%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
19,060
Price
$13.37
Total Value
$254.83K
Shares Held After
486,244
% of Holdings
3.8%
Kalaris Therapeutics, Inc. (KLRS)
Hagen Brett R — Chief Accounting Officer
Shares
1,915
Price
$6.72
Total Value
$12.87K
Shares Held After
0
% of Holdings
100.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
320
Price
$529.08
Total Value
$169.30K
Shares Held After
40,513
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
865
Price
$527.99
Total Value
$456.71K
Shares Held After
40,833
% of Holdings
2.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
993
Price
$527.08
Total Value
$523.39K
Shares Held After
41,698
% of Holdings
2.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
660
Price
$526.06
Total Value
$347.20K
Shares Held After
42,691
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,815
Price
$525.02
Total Value
$952.91K
Shares Held After
43,351
% of Holdings
4.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,749
Price
$524.18
Total Value
$1.44M
Shares Held After
45,166
% of Holdings
5.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,538
Price
$523.28
Total Value
$804.81K
Shares Held After
47,915
% of Holdings
3.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
520
Price
$521.69
Total Value
$271.28K
Shares Held After
49,453
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$520.34
Total Value
$20.81K
Shares Held After
49,973
% of Holdings
0.1%
Maze Therapeutics, Inc. (MAZE)
Bernstein Harold — President, R&D & CMO
Shares
5,044
Price
$50.02
Total Value
$252.29K
Shares Held After
0
% of Holdings
100.0%
Maze Therapeutics, Inc. (MAZE)
Bernstein Harold — President, R&D & CMO
Shares
3,795
Price
$49.32
Total Value
$187.17K
Shares Held After
5,044
% of Holdings
42.9%
Maze Therapeutics, Inc. (MAZE)
Bernstein Harold — President, R&D & CMO
Shares
6,161
Price
$48.20
Total Value
$296.98K
Shares Held After
8,839
% of Holdings
41.1%
Kymera Therapeutics, Inc. (KYMR)
Esposito Pamela — Director
Shares
1,200
Price
$79.94
Total Value
$95.93K
Shares Held After
0
% of Holdings
100.0%
Kymera Therapeutics, Inc. (KYMR)
Esposito Pamela — Director
Shares
600
Price
$79.24
Total Value
$47.55K
Shares Held After
1,200
% of Holdings
33.3%
Kymera Therapeutics, Inc. (KYMR)
Esposito Pamela — Director
Shares
700
Price
$77.71
Total Value
$54.40K
Shares Held After
1,800
% of Holdings
28.0%
Bicara Therapeutics Inc. (BCAX)
Mazumdar Claire — Director
Shares
1,596
Price
$18.95
Total Value
$30.25K
Shares Held After
339,392
% of Holdings
0.5%
Showing 551–600 of 1094 transactions (page 12 of 22)